182 filings
Page 4 of 10
DEFA14A
wfbx28pdft7u0vtlz
26 Apr 22
Additional proxy soliciting materials
7:04am
S-8
wbn2xi1c5uwmi1 jlx
2 Mar 22
Registration of securities for employees
7:53am
8-K
6y1f qgs6zg88gbm
2 Mar 22
Surface Oncology Reports Financial Results and Corporate Highlights for Fourth Quarter and Full Year 2021
7:02am
8-K
4p13uqq9
15 Dec 21
Surface Oncology Appoints Denice Torres as Chair of the Board of Directors
7:00am
8-K
m18wpac
6 Dec 21
Surface Oncology Presents Promising Clinical Data on SRF617 at the European Society for Medical Oncology Immuno-Oncology Congress (ESMO-IO) 2021
9:27am
8-K
13zimkmkd46
4 Nov 21
Surface Oncology Reports Financial Results and Corporate Highlights for Third Quarter 2021
7:01am
8-K
7guc gj81yx
4 Oct 21
Entry into a Material Definitive Agreement
7:05am
EFFECT
wimlqp9ajl 9id0893ck
16 Aug 21
Notice of effectiveness
12:15am
CORRESP
aixww3t4
11 Aug 21
Correspondence with SEC
12:00am
UPLOAD
9244o4nu
11 Aug 21
Letter from SEC
12:00am
8-K
rty7yf9v
5 Aug 21
Surface Oncology Reports Financial Results and Corporate Highlights for Second Quarter 2021
7:02am
8-K
m1ydni6
8 Jul 21
Surface Oncology Appoints Denice Torres to Board of Directors
7:05am
8-K
eajzdwjha572jh69s
10 Jun 21
Submission of Matters to a Vote of Security Holders
8:00am
8-K
1by3xk24n3cztg 97k
4 Jun 21
SRF388, a First-in-Class IL-27 Antibody, Demonstrates Monotherapy Activity in Data Presented at American Society of Clinical Oncology Annual Meeting
7:15am